Prevention of Central Venous Catheter-associated Thrombosis in Critically Ill Children: A Multicenter Phase 2b Trial

Trial Profile

Prevention of Central Venous Catheter-associated Thrombosis in Critically Ill Children: A Multicenter Phase 2b Trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 May 2018

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Deep vein thrombosis
  • Focus Therapeutic Use
  • Acronyms CRETE
  • Most Recent Events

    • 19 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
    • 19 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
    • 12 Oct 2017 Planned number of patients changed from 50 to 100.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top